GHP Investment Advisors Inc. trimmed its stake in Plexus Corp. (NASDAQ:PLXS – Free Report) by 3.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 84,023 shares of the technology company’s stock after selling 3,045 shares during the quarter. GHP Investment Advisors Inc.’s holdings in Plexus were worth $13,148,000 at the end of the most recent quarter.
Other institutional investors also recently made changes to their positions in the company. Pacer Advisors Inc. acquired a new position in Plexus in the fourth quarter valued at $107,489,000. Disciplined Growth Investors Inc. MN grew its position in Plexus by 2.8% during the third quarter. Disciplined Growth Investors Inc. MN now owns 2,168,512 shares of the technology company’s stock valued at $296,457,000 after acquiring an additional 59,465 shares during the period. Assenagon Asset Management S.A. grew its position in Plexus by 158.0% during the third quarter. Assenagon Asset Management S.A. now owns 82,575 shares of the technology company’s stock valued at $11,289,000 after acquiring an additional 50,564 shares during the period. Algert Global LLC grew its position in Plexus by 1,546.5% during the third quarter. Algert Global LLC now owns 45,790 shares of the technology company’s stock valued at $6,260,000 after acquiring an additional 43,009 shares during the period. Finally, Barclays PLC grew its position in Plexus by 139.4% during the third quarter. Barclays PLC now owns 48,786 shares of the technology company’s stock valued at $6,669,000 after acquiring an additional 28,406 shares during the period. 94.45% of the stock is owned by institutional investors and hedge funds.
Plexus Price Performance
Shares of NASDAQ PLXS opened at $142.39 on Thursday. The company has a market capitalization of $3.86 billion, a price-to-earnings ratio of 33.04 and a beta of 0.89. Plexus Corp. has a 1-year low of $90.18 and a 1-year high of $172.89. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. The business has a 50-day moving average of $159.43 and a 200-day moving average of $143.56.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the company. StockNews.com raised Plexus from a “hold” rating to a “buy” rating in a research report on Monday, November 18th. Needham & Company LLC boosted their price target on Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a research report on Friday, January 24th. KeyCorp assumed coverage on Plexus in a research report on Tuesday, October 22nd. They set a “sector weight” rating for the company. Benchmark reissued a “buy” rating and set a $165.00 price target on shares of Plexus in a research report on Wednesday, January 22nd. Finally, Stifel Nicolaus started coverage on Plexus in a research report on Tuesday. They issued a “hold” rating and a $152.00 target price for the company. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, Plexus currently has an average rating of “Moderate Buy” and a consensus price target of $163.00.
View Our Latest Report on PLXS
Insider Transactions at Plexus
In related news, CEO Todd P. Kelsey sold 4,337 shares of the firm’s stock in a transaction that occurred on Wednesday, February 5th. The stock was sold at an average price of $142.23, for a total value of $616,851.51. Following the sale, the chief executive officer now directly owns 80,595 shares in the company, valued at $11,463,026.85. This trade represents a 5.11 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Angelo Michael Ninivaggi, Jr. sold 3,423 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $145.14, for a total value of $496,814.22. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $4,281,775.14. This represents a 10.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,239 shares of company stock worth $2,212,730. 1.76% of the stock is currently owned by company insiders.
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Further Reading
- Five stocks we like better than Plexus
- Where Do I Find 52-Week Highs and Lows?
- Volatility is Back: 3 Must-Have Stocks to Weather the Storm
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- BigBear.ai: Can New Leadership and Deregulation Unlock Growth?
- How to invest in marijuana stocks in 7 stepsĀ
- Powering Profits: Utility Stocks That Shine in Volatility
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.